<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02731092</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-HSR 18130</org_study_id>
    <nct_id>NCT02731092</nct_id>
  </id_info>
  <brief_title>Safety and Tolerability of Lactoferrin in Very Low Birth Weight Infants</brief_title>
  <official_title>Safety and Tolerability of Lactoferrin in Very Low Birth Weight Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Gerber Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and tolerability of three different lactoferrin doses in preterm
      infants
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim1: To evaluate the safety and tolerability of three different lactoferrin doses in preterm
      infants

        1. Lactoferrin related adverse events and serious adverse events

        2. Number of infants reaching full feeds while receiving lactoferrin (120 ml/kg/day)

        3. Episodes of not receiving enteral feedings for &gt; 24 hours once feeding is initiated

      Aim 2: To evaluate lactoferrin absorption and excretion.

        1. Examine lactoferrin levels in saliva, urine, plasma and stool

        2. Examine lactoferrin levels in maternal and human donor milk.

      Aim 3: To evaluate the effect of lactoferrin on the intestinal microbiome structure.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Definitely related study solution serious adverse event</measure>
    <time_frame>30 days while receiving study solution</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of infants reaching 120 ml/kg of enteral feeds</measure>
    <time_frame>30 days while receiving study solution</time_frame>
    <description>Number of infants reaching 120 ml/kg of enteral feeds while receiving study solution</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days not receiving any feedings after lactoferrin administration</measure>
    <time_frame>30 days while receiving study solution</time_frame>
    <description>Number of days not receiving any feedings after lactoferrin administration begun</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Very Low Birth Weight Infants</condition>
  <arm_group>
    <arm_group_label>Lactoferrin 100 mg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 mg/kg enteral administration daily for 30 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lactoferrin 200 mg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>200 mg/kg enteral administration daily for 30 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lactoferrin 300 mg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>300 mg/kg enteral administration daily for 30 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactoferrin</intervention_name>
    <description>Bovine Lactoferrin 100 mg/ml dissolved in sterile water</description>
    <arm_group_label>Lactoferrin 100 mg/kg</arm_group_label>
    <arm_group_label>Lactoferrin 200 mg/kg</arm_group_label>
    <arm_group_label>Lactoferrin 300 mg/kg</arm_group_label>
    <other_name>BioferrinÂ® 2000</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &lt; 15 days of age and receiving enteral feedings

          -  &lt; 1500 grams birth weight

          -  &lt;37 weeks gestation

        Exclusion Criteria:

          -  Congenital bowel obstruction ( esophageal, duodenal, small bowel or anal atresias,
             Hirschsprung disease, malrotation)

          -  Known necrotizing enterocolitis or bowel perforation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David A Kaufman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David A Kaufman, MD</last_name>
    <phone>4349245428</phone>
    <email>dak4r@virginia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Virginia Neonatal Intensive Care Unit</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Kaufman, MD</last_name>
      <phone>434-924-9114</phone>
      <email>Dak4r@virginia.edu</email>
    </contact>
    <investigator>
      <last_name>David Kaufman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia HealthSystem</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22932</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David A Kaufman, MD</last_name>
      <phone>434-924-5428</phone>
      <email>dak4r@virginia.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2016</study_first_submitted>
  <study_first_submitted_qc>April 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2016</study_first_posted>
  <last_update_submitted>April 18, 2016</last_update_submitted>
  <last_update_submitted_qc>April 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>David A Kaufman</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>lactoferrin</keyword>
  <keyword>very low birth weight infants</keyword>
  <keyword>preterm infants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Birth Weight</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactoferrin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>At UVA and MTA with outside institutions</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

